Development of multiple cell-based assays for the detection of histone h3 lys27 trimethylation (H3K27me3)

Assay and Drug Development Technologies

Volumn 11, Issue 7, 2013, Pages 449-456

  Qian, Jie ^a   Lu, Lihui ^a   Wu, Jianghong ^a   Ma, Haiching ^a  

^a REACTION BIOLOGY CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; GREEN FLUORESCENT PROTEIN; HISTONE H3; TERBIUM; TRIMETHYL HISTONE H3 LYSINE 27; UNCLASSIFIED DRUG; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTONE;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL ACTIVITY; CELL ASSAY; CELL CULTURE; CELL DENSITY; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYOPRESERVATION; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; HIGH THROUGHPUT SCREENING; HISTONE METHYLATION; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INTERMETHOD COMPARISON; LASER; LYMPHOMA CELL LINE; MULTIPLE CELL BASED ASSAY; PROSTATE CARCINOMA; ROOM TEMPERATURE; UTERINE CERVIX CANCER; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BATCH CELL CULTURE; BIOASSAY; CHEMISTRY; DEVICE FAILURE ANALYSIS; DEVICES; DRUG EFFECTS; EQUIPMENT DESIGN; EXPERIMENTAL NEOPLASM; GENETIC PROCEDURES; IMMUNOASSAY; METABOLISM; METHYLATION; TISSUE MICROARRAY; TUMOR CELL LINE; VALIDATION STUDY;

BATCH CELL CULTURE TECHNIQUES; BIOLOGICAL ASSAY; BIOSENSING TECHNIQUES; CELL LINE, TUMOR; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HIGH-THROUGHPUT SCREENING ASSAYS; HISTAMINE H3 ANTAGONISTS; HISTONES; HUMANS; IMMUNOASSAY; METHYLATION; NEOPLASMS, EXPERIMENTAL; TISSUE ARRAY ANALYSIS;

EID: 84884550466     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2013.515     Document Type: Article

References (18)

1. Wolffe AP, Matzke MA: Epigenetics: regulation through repression. Science 1999;286:481-486.
2. Jenuwein T: The epigenetic magic of histone lysine methylation. FEBS J 2006; 273:3121-3135.
3. Zhou VW, Goren A, Bernstein BE: Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011;12:7-18.
4. Roth SY, Allis CD: Histone acetylation and chromatin assembly: a single escort, multiple dances? Cell 1996;87:5-8. (Pubitemid 26337384)
5. Jenuwein T, Allis CD: Translating the histone code. Science 2001;293: 1074-1080. (Pubitemid 32758077)
6. Sneeringer CJ, Scott MP, Kuntz KW, et al.: Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci USA 2010;107:20980-20985.
7. Bissinger EM, Heinke R, Sippl W, Jung M: Histone methyltransferase inhibitors. Med Chem Commun 2010;1:114-124.
8. Chang MJ, Wu H, Achille MJ, et al.: Histone H3 lysine 79 methyltransferase dot1 is required for immortalization by mll oncogenes. Cancer Res 2010;70: 10234-10242.
9. Lu Q, Patel MP, Semus SF, et al.: Perspectives on the discovery of small-molecule modulators for epigenetic processes. J Biomol Screen 2012;17:555-571.
10. McCabe MT, Ott HM, Ganji G, et al.: EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012;492:108-112.
11. Wang C, Caron M, Burdick D, et al.: A sensitive, homogeneous, and highthroughput assay for lysine-specific histone demethylases at the H3K4 site. Assay Drug Dev Technol 2012;10:179-186.
12. Diaz E, Machutta CA, Chen S, et al.: Development and validation of reagents and assays for EZH2 peptide and nucleosome high-throughput screens. J Biomol Screen 2012;17:1279-1292.
13. Horiuchi KY, Eason MM, Ferry JJ, et al.: Assay development for histone methyltransferases. Assay Drug Dev Technol 2013;11:227-236.
14. Quinn AM, Allali-Hassani A, Vedadi M, and Simeonov A: A chemiluminescencebased method for identification of histone lysine methyltransferase inhibitors. Mol Biosyst 2010;6;782-788.
15. Quinn AM, Bedford MT, Espejo A, et al.: A homogeneous method for investigation of methylation-dependent protein-protein interactions in epigenetics. Nucleic Acids Res 2010;38:e11.
16. Xie W, Ames RS, Li H: A cell-based high-throughput screening assay to measure cellular histone H3 lys27 trimethylation with a modified dissociation-enhanced lanthanide fluorescent immunoassay. J Biomol Screen 2012;17:99-107.
17. Machleidt T, Robers MB, Hermanson SB, Dudek JM, Bi K: TR-FRET cellular assays for interrogating posttranslational modifications of histone H3. J Biomol Screen 2011;16:1236-1246.
18. Miranda TB, Cortez CC, Yoo CB, et al.: DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009;8:1579-1588.